Catecholaminergic Modulation of Metacontrol Is Reflected in Aperiodic EEG Activity and Predicted by Baseline GABA + and Glx Concentrations
Human Brain Mapping · 2025
DOI: 10.1002/hbm.70173 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Brain Mapping, 2025. Verfasst von Yang Gao und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Psychology, Shandong Normal University, Jinan, China. Hauptthemen laut MEDLINE: gamma-Aminobutyric Acid, Electroencephalography, Glutamic Acid, Executive Function. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Natural Science Foundation of Shandong Province, Bundesministerium für Bildung und Forschung.
Abstract (Originalsprache)
The ability to balance between being persistent versus flexible during cognitive control is referred to as “metacontrol” and reflected in the exponent of aperiodic neural activity. Theoretical considerations suggest that metacontrol is affected by the interplay of the GABAergic, glutamatergic, and catecholaminergic systems. Moreover, evidence suggests that fronto‐striatal structures play an important role. Yet, the nexus between neurobiochemistry and structural neuroanatomy when it comes to the foundations of metacontrol is not understood. To examine this, we investigated how an experimental manipulation of catecholaminergic signaling via methylphenidate (MHP) and baseline levels of GABA and glutamate in the anterior cingulate cortex (ACC), supplementary motor area (SMA), and striatum as assessed via MR spectroscopy altered task performance and associated aperiodic activity (assessed via EEG) during a conflict monitoring task. We investigated N = 101 healthy young adults. We show that the EEG‐aperiodic exponent was elevated during task performance, as well as during cognitively challenging task conditions requiring more persistent processing and was further enhanced by MPH administration. Correlation analyses also provided evidence for an important role of individual characteristics and dispositions as reflected by the observed role of GABA+ and Glx baseline levels in the ACC, the SMA, and the striatum. Our observations point to an important role of catecholamines in the amino acid neurotransmitter‐driven regulation of metacontrol and task‐specific (changes in) metacontrol biases. The results suggest an interplay of the GABA/Glx and the catecholaminergic system in prefrontal‐basal ganglia structures crucial for metacontrol.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Psychology, Shandong Normal University, Jinan, China.
- Cognitive Neurophysiology, Department of Child and Adolescent Psychiatry, Faculty of Medicine, TU Dresden, Dresden, Germany.
- German Center for Child and Adolescent Health (DZKJ), Partner Site Leipzig/Dresden, Dresden, Germany.
Förderung
- Deutsche Forschungsgemeinschaft
- Natural Science Foundation of Shandong Province
- Bundesministerium für Bildung und Forschung
Zitieren
APA
Gao, Y., Koyun, A. H., Stock, A. K., Werner, A., Roessner, V., Colzato, L., Hommel, B., & Beste, C. (2025). Catecholaminergic Modulation of Metacontrol Is Reflected in Aperiodic EEG Activity and Predicted by Baseline GABA + and Glx Concentrations. Human Brain Mapping. https://doi.org/10.1002/hbm.70173
Vancouver
Gao Y, Koyun AH, Stock AK, Werner A, Roessner V, Colzato L, et al. Catecholaminergic Modulation of Metacontrol Is Reflected in Aperiodic EEG Activity and Predicted by Baseline GABA + and Glx Concentrations. Human Brain Mapping. 2025. doi:10.1002/hbm.70173
BibTeX
@article{Gao2025,
author = {Gao, Yang and Koyun, Anna Helin and Stock, Ann-Kathrin and Werner, Annett and Roessner, Veit and Colzato, Lorenza and Hommel, Bernhard and Beste, Christian},
title = {Catecholaminergic Modulation of Metacontrol Is Reflected in Aperiodic EEG Activity and Predicted by Baseline GABA + and Glx Concentrations},
journal = {Human Brain Mapping},
year = {2025},
doi = {10.1002/hbm.70173}
}
EUVIMED